A detailed history of Eagle Asset Management Inc transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Eagle Asset Management Inc holds 82,791 shares of AXSM stock, worth $8.6 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
82,791
Previous 98,645 16.07%
Holding current value
$8.6 Million
Previous $7.94 Million 6.32%
% of portfolio
0.04%
Previous 0.04%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$78.93 - $95.84 $1.25 Million - $1.52 Million
-15,854 Reduced 16.07%
82,791 $7.44 Million
Q2 2024

Aug 12, 2024

SELL
$65.72 - $80.5 $8.4 Million - $10.3 Million
-127,870 Reduced 56.45%
98,645 $7.94 Million
Q1 2024

May 09, 2024

BUY
$69.39 - $97.64 $15.7 Million - $22.1 Million
226,515 New
226,515 $18.1 Million

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $4.45B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Eagle Asset Management Inc Portfolio

Follow Eagle Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Asset Management Inc with notifications on news.